The chemical composition of uric acid was identified by a Swedish chemist in 1797, and by 1940, the understanding of uric acid metabolism, including its excretion and overproduction was established
Public awareness moved from clinical journals to celebrity feeds within months
The standard regimen involves weekly self-administered injections, with dose adjustments made by your medical provider as needed throughout the program
Regarding the secondary endpoint hospitalization due to heart failure, the results of the studies are heterogenous
Latin America The Latin America GLP-1 Receptor Agonist Market size was valued at USD 1,633.06 million in 2018 to USD 3,002.90 million in 2024 and is anticipated to reach USD 10,633.77 million by 2032, at a CAGR of 17.2% during the forecast period